SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-016529
Filing Date
2023-10-19
Accepted
2023-10-19 07:00:10
Documents
14
Period of Report
2023-10-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20231017x8k.htm   iXBRL 8-K 52213
2 EX-10.1 tmb-20231017xex10d1.htm EX-10.1 113527
3 EX-99.1 tmb-20231017xex99d1.htm EX-99.1 12979
  Complete submission text file 0001558370-23-016529.txt   329324

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20231017.xsd EX-101.SCH 3109
5 EX-101.LAB tmb-20231017_lab.xml EX-101.LAB 15268
6 EX-101.PRE tmb-20231017_pre.xml EX-101.PRE 10906
8 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20231017x8k_htm.xml XML 4692
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 6123798854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

IRS No.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-17272 | Film No.: 231333334
SIC: 2836 Biological Products, (No Diagnostic Substances)